SAK CORP's Net Worth

$1.21 Billion

Estimate Recalculated Feb 7, 2024 04:07PM EST

Who is SAK CORP?

SAK CORP has an estimated net worth of $1.21 Billion. This is based on reported shares across multiple companies, which include Orexigen Therapeutics, Inc., IDENIX PHARMACEUTICALS INC, BreitBurn Energy Partners L.P., KERYX BIOPHARMACEUTICALS INC, FACET BIOTECH CORP, and RHI Entertainment, Inc..

SEC CIK

SAK CORP's CIK is 0001061088

Past Insider Trading and Trends

2008 was SAK CORP's most active year for acquiring shares with 1 total transactions. SAK CORP's most active month to acquire stocks was the month of December. 2009 was SAK CORP's most active year for disposing of shares, totalling 5 transactions. SAK CORP's most active month to dispose stocks was the month of August. 2014 saw SAK CORP paying a total of $106,731,566.50 for 16,420,241 shares, this is the most they've acquired in one year. In 2014 SAK CORP cashed out on 53,331,109 shares for a total of $1,306,612,170.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Orexigen Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

IDENIX PHARMACEUTICALS INC No price found

Investor

SAK CORP owns 53,331,109 units of Common Stock. In the year 2013 SAK CORP acquired a total of 16,420,241 shares in IDENIX PHARMACEUTICALS INC at a cost of $106,731,566.50, SAK also disposed a total of 53,331,109 shares of IDENIX PHARMACEUTICALS INC equalling to $1,306,612,170.50.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-53.33M
$24.50
-$1,306,612,170.50
0
Aug 5
Form 4
+44.49%
16.42M
$6.50
$106,731,566.50
53.33M
Jan 31
Form 3
0
0
No matching records found

BreitBurn Energy Partners L.P. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

KERYX BIOPHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

FACET BIOTECH CORP No price found

Investor

SAK CORP owns 3,506,875 units of Common Stock, $0.01 par value per share. In the year 2009 SAK CORP filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-19.83%
-867.53K
$15.43
-$13,382,286.09
3.51M
Sep 4
Form 3
0
0
No matching records found